IRadimed
- Market cap
- 1.09B
- P/E (TTM)i
- 47.75
- P/Bi
- 10.74
- EPSi
- 1.75
- Div yieldi
- 0.87%
- 52W posi
- 41%
Anonymous reader poll. Unscientific, not investment advice.
IRadimed last traded at 85.47, up 0.77% on the session. At current prices, the business is worth about 1.09B, the #3190 most valuable US-listed company we track. The trailing P/E of 47.75 is 8% above its five-year average of 44.09. Income-focused holders are looking at a trailing yield of 0.87% here. Wall Street's 2-analyst consensus lands on Buy, with a price target averaging 120.00 (+40% from here). Over the past year the stock has ranged from 70.37 to 107.20; it now sits 41% up that band.
✦ StockVane Quant Insights how this is computed
- Not yet in the StockVane Momentum strategy's universe - this name needs price history back to 2021 for a reliable signal and doesn't have it yet (most often because it IPO'd or was spun off more recently). This grade is a preliminary blend of valuation, momentum and analyst data, not a Momentum buy/sell call.
- Valuation sits at the 77% percentile of its own 5-year range.
- Price momentum averages +1.0% across the trailing 3-month/1-year windows.
- Analyst consensus across 2 analysts is Buy.
- Recent price momentum is +1.0% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 5.5% of float.
- Analyst tilt is Buy.
- Price is above its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 84.82
- Open
- 84.55
- Day range
- 83.84 - 86.77
- Avg price
- 85.39
- Volume
- 197.89K
- Turnover
- 16.90M
- Turnover ratei
- 2.38%
- Volume ratioi
- 1.57
- Amplitudei
- 3.45%
- 52-week rangei
- 70.37 - 107.20
Valuation
- P/Ei
- 48.84
- P/E (TTM)i
- 47.75
- P/Bi
- 10.74
- EPSi
- 1.75
- Book value / shi
- 7.96
- Net profit
- 22.38M
- Net assets
- 101.75M
Share structure
- Market cap
- 1.09B
- Float capi
- 711.98M
- Shares out
- 12.79M
- Float sharesi
- 8.33M
Dividend & listing
- Div yield (TTM)i
- 0.87%
- Dividend (TTM)
- 0.74
- Listing date
- --
20.3% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-3.48M net over the window
Short interest
- Shares short
- 700.01K
- % of floati
- 5.47%
- Days to coveri
- 5.70
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of IRadimed (IRMD)?
IRadimed last traded at 85.47. The quote on this page refreshes every few seconds while US markets are open.
What is IRadimed's market cap?
About 1.09B.
What is the P/E ratio of IRadimed?
The trailing twelve-month P/E is 47.75, above its own 5-year average of 44.09 — toward the top of its historical range (72.15% percentile). See the Valuation tab for the full history.
Does IRadimed pay a dividend?
Yes. The trailing dividend yield is 0.87%. The 2025 payout was up 162.2% from 2024. See the Dividends tab for the full payment history.
Is IRadimed a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 120.00, which implies 40.4% upside from the current price. This is not investment advice.
Quote time 2026-10-08 08:10:28 · For reference only, not investment advice and not tailored to your situation.